Ori Biotech’s CEO said the prioritization of review by FDA, coupled to the impact of the technology, could shave up to three ...

New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.

Though brain chips are all over TV and the news now with Neuralink, scientists like those at Caltech have been working on the ...

Apple unveils iPhone 17 lineup, new AirPods Pro, and upgraded smartwatches ahead of the holiday shopping season. Newsweek's ...

Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and ...

The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...

Rapid scientific advances are accelerating the development of medical innovations, from personalized treatments to curative ...

The FDA's new 'green list' is meant to prevent unverified and unapproved GLP-1 drug ingredients from entering the country.

To harness the full potential of new medical technologies, a new white paper calls for significant FDA reforms to streamline clinical trials, provide greater certainty for innovators and speed ...

A research team has developed an implantable wireless neural interface capable of delivering drugs precisely to deep regions ...

Travere Therapeutics (NASDAQ:TVTX) climbed ~27% in the premarket on Wednesday after the company said that the FDA has ...